Enovix Corp
ENVX Nasdaq Miscellaneous Electrical Machinery, Equipment & Supplies Financials FY2020βFY2025
What Enovix Corp does
No business description yet.
- Legal name
- Enovix Corp
- Fiscal year ends
- December 28, 2025
- Latest annual report
- 10-K Β· Feb 25, 2026
- Accession Β· CIK
- 0001828318-26-000006
0001828318
Revenue and margins
Enovix Corp had $31.8M of revenue in fiscal 2025, up 37.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$114M in fiscal 2025, β356.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Enovix Corp returned $58.4M to shareholders in fiscal 2025. The diluted share count rose 11.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Enovix Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $385M | $323M | $307M | $273M | $512M |
| Debt incl. finance leases | β | $0.0M | $175M | $179M | $529M |
| Debt / equity | β | 0.0x | 0.7x | 0.7x | 2.0x |
| Interest coverage | β371.8x | β | β51.7x | β35.8x | β8.2x |
| Current ratio | 19.3x | 14.3x | 5.3x | 5.5x | 8.3x |
| Quick ratio | 19.3x | 14.3x | 5.2x | 5.4x | 8.1x |
| Total assets | $483M | $441M | $564M | $527M | $879M |
| Total liabilities | $156M | $84.2M | $303M | $278M | $605M |
| Shareholders' equity | $326M | $356M | $258M | $247M | $271M |
| Net debt (β = net cash) | β | β$323M | β$132M | β$93.6M | $17.2M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 7 | 2 / 7 | 1 / 9 | 4 / 9 | 4 / 9 |
| Accruals ratio | β30.2% | β27.2% | 6.7% | β21.8% | β20.8% | β8.7% |
| Altman Z'' | β9.27 | 4.10 | 4.15 | β2.26 | β4.24 | β0.95 |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $0.0M | $0.0M | $6.2M | $7.6M | $23.1M | $31.8M |
| Net interest income | β$0.1M | β$0.2M | $5.2M | β | β | β |
| Gross profit | β$3.4M | β$2.0M | β$17.0M | β$55.4M | β$2.0M | $6.1M |
| Research and development | $14.4M | $37.9M | $58.1M | $88.4M | $125M | $110M |
| Operating income | β$23.5M | β$69.5M | β$132M | β$230M | β$243M | β$177M |
| Interest expense | β | $0.2M | $0.0M | $4.5M | $6.8M | $21.6M |
| Pretax income | β$39.7M | β$126M | β$51.6M | β$215M | β$224M | β$158M |
| Income tax | $0.0M | $0.0M | $0.0M | β$0.6M | β$1.4M | β$1.3M |
| Net income | β$39.7M | β$126M | β$51.6M | β$214M | β$222M | β$157M |
| Net income to common | β$39.7M | β$126M | β$51.6M | β$214M | β$222M | β$157M |
| Diluted EPS | β$0.49 | β$1.07 | β$0.82 | β$1.30 | β$1.19 | β$0.75 |
| Diluted shares | 0.08B | 0.12B | 0.15B | 0.17B | 0.19B | 0.21B |
| Cash flow | ||||||
| Cash from operations | β$20.1M | β$51.3M | β$82.7M | β$105M | β$109M | β$95.3M |
| Capital expenditure | $27.0M | $43.6M | $36.2M | $61.8M | $76.2M | $18.2M |
| Free cash flow | β$47.0M | β$94.9M | β$119M | β$166M | β$185M | β$114M |
| Depreciation and amortization | $1.0M | $1.5M | $8.0M | $34.0M | $45.0M | $35.1M |
| Stock-based compensation | $0.7M | $10.7M | $30.4M | $69.5M | $58.8M | $49.4M |
| Acquisitions | β | $0.0M | $0.0M | $10.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $58.4M |
| Dividends and buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $58.4M |
| Balance sheet | ||||||
| Cash and short-term investments | $29.1M | $385M | $323M | $307M | $273M | $512M |
| Total debt | β | β | $0.0M | $175M | $179M | $529M |
| Current assets | $33.0M | $398M | $330M | $323M | $295M | $542M |
| Current liabilities | $10.9M | $20.6M | $23.0M | $61.0M | $53.7M | $65.0M |
| Inventory | β | $0.0M | $0.6M | $8.7M | $7.7M | $13.6M |
| Property and equipment, net | $31.3M | $76.6M | $104M | $166M | $168M | $170M |
| Goodwill | β | β | $0.0M | $12.1M | $12.2M | $12.2M |
| Intangible assets | β | β | $0.0M | $42.2M | $36.4M | $31.6M |
| Total assets | $65.0M | $483M | $441M | $564M | $527M | $879M |
| Total liabilities | $28.7M | $156M | $84.2M | $303M | $278M | $605M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | β |
| Shareholders' equity | $36.2M | $326M | $356M | $258M | $247M | $271M |
| Margins | ||||||
| Gross margin | β | β | β274.7% | β725.0% | β8.9% | 19.2% |
| Operating margin | β | β | β2,128.0% | β3,012.2% | β1,051.7% | β557.0% |
| EBITDA margin | β | β | β1,999.5% | β2,567.3% | β856.8% | β446.7% |
| Net margin | β | β | β832.3% | β2,800.5% | β963.2% | β492.6% |
| FCF margin | β | β | β1,918.0% | β2,177.3% | β801.0% | β356.7% |
| Net interest share of revenue | β | β | 84.3% | β | β | β |
| Returns | ||||||
| Return on capital | β | β | β310.5% | β144.0% | β125.2% | β48.6% |
| Return on capital employed | β43.5% | β15.1% | β31.6% | β45.8% | β51.3% | β21.8% |
| Return on equity | β109.5% | β69.5% | β15.1% | β69.7% | β88.0% | β60.5% |
| Return on assets | β61.0% | β46.0% | β11.2% | β42.6% | β40.7% | β22.3% |
| Return on tangible equity | β109.5% | β38.6% | β14.5% | β105.0% | β112.2% | β68.9% |
| Growth | ||||||
| Revenue growth | β | β | β | 23.3% | 201.9% | 37.9% |
| Share count change | β | 45.9% | 31.5% | 10.0% | 9.7% | 11.6% |
| Financial health | ||||||
| Debt / equity | β | β | 0.0x | 0.7x | 0.7x | 2.0x |
| Interest coverage | β | β371.8x | β | β51.7x | β35.8x | β8.2x |
| Current ratio | 3.0x | 19.3x | 14.3x | 5.3x | 5.5x | 8.3x |
| Quick ratio | 3.0x | 19.3x | 14.3x | 5.2x | 5.4x | 8.1x |
| Capital allocation | ||||||
| Capex / revenue | β | β | 583.9% | 808.4% | 330.2% | 57.3% |
| Stock comp / revenue | β | β | 489.6% | 908.6% | 255.0% | 155.1% |
| Quality scores | ||||||
| Piotroski F-score | β | 3.0 | 2.0 | 1.0 | 4.0 | 4.0 |
| Altman Z'' | β9.3 | 4.1 | 4.2 | β2.3 | β4.2 | β0.9 |
| Accruals ratio | β30.2% | β27.2% | 6.7% | β21.8% | β20.8% | β8.7% |
Source: SEC EDGAR XBRL filings (CIK 0001828318). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.